Department of Neurosurgery, Hospital Clínico San Carlos, San Carlos Research Health Institute (IdISSC), Madrid, Spain; Universidad Complutense, Madrid, Spain, Madrid, Spain.
HM CINAC, Hospital Universitario HM Puerta Del Sur, Universidad CEU-San Pablo, Móstoles, Madrid, Spain.
Brain Stimul. 2022 May-Jun;15(3):727-736. doi: 10.1016/j.brs.2022.04.015. Epub 2022 Apr 28.
Directional subthalamic stimulation in Parkinson's disease can increase stimulation threshold for adverse effects and widen the therapeutic window. However, selection of programming settings is time consuming, requiring a thorough monopolar clinical review. To overcome this, programming may be guided by intraoperatively recording local field potential beta oscillations (13-35 Hz).
We conducted a non-randomized, prospective study with 24 Parkinson's disease patients divided into two groups. In group A (14 patients, 2016-2018), we investigated whether beta activity in the directional contacts correlated with clinical efficacy. Stimulating parameters were selected according to clinical monopolar review and mean follow-up was 27 months. In group B (10 patients, 2018-2019), stimulating parameters were selected according to beta activity and mean follow-up was 13 months.
Neurophysiological results showed a strong correlation between clinical efficacy and the low-beta sub-band. Contacts with highest beta peaks increased the therapeutic window by 25%. Selecting the two contacts with highest beta peaks provided an 82% probability of selecting the best clinical contact. Clinical results showed similar improvements in group A (motor score, 72% reduction; levodopa-equivalent daily dose, 65% reduction) and B (72% and 63% reduction, respectively), maintained at long-term follow-up.
Our results validate the long-term efficacy of directional stimulation guided by intraoperative local field potential beta oscillations.
在帕金森病中,定向丘脑下刺激可以增加不良反应的刺激阈值并扩大治疗窗口。然而,编程设置的选择很耗时,需要彻底进行单极临床审查。为了克服这一问题,可以通过术中记录局部场电位β振荡(13-35 Hz)来指导编程。
1)评估术中记录的β振荡功率是否可以预测临床上最有效的定向接触;2)评估基于临床单极审查和基于β活动编程的患者之间的长期定向刺激结果。
我们进行了一项非随机、前瞻性研究,纳入 24 名帕金森病患者,分为两组。在 A 组(14 名患者,2016-2018 年)中,我们研究了定向接触中的β活动是否与临床疗效相关。刺激参数根据临床单极审查选择,平均随访时间为 27 个月。在 B 组(10 名患者,2018-2019 年)中,根据β活动选择刺激参数,平均随访时间为 13 个月。
神经生理学结果显示,临床疗效与低β子带之间存在很强的相关性。β峰值最高的接触可将治疗窗口增加 25%。选择具有最高β峰值的两个接触可提供 82%的概率选择最佳临床接触。临床结果显示,A 组(运动评分降低 72%;左旋多巴等效日剂量降低 65%)和 B 组(分别降低 72%和 63%)的改善相似,在长期随访中得到维持。
我们的结果验证了术中局部场电位β振荡引导的定向刺激的长期疗效。